Copy Link Print Information

Bavunalimab

(Synonyms: Anti-Human CTLA4xLAG3; XmAb-22841; Pavunalimab)
Revisión del cliente

Based on 1 Customer Validation

Bavunalimab (Anti-Human CTLA4xLAG3) is a bispecific human anti-CTLA-4/LAG-3 monoclonal antibody. Bavunalimab activates T cells in NSG mice. Bavunalimab can be used for the research of cancer.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.408%
  • No. CAS: 2329669-78-3
  • Peso molecular:125.327 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Bavunalimab
  • Experimental Validation Results for Bavunalimab
  • Experimental Validation Results for Bavunalimab
  • Experimental Validation Results for Bavunalimab
  • Bavunalimab Chemical Structure
    Bavunalimab Chemical Structure
No. CAS: 2329669-78-3
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Bavunalimab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    half-IGG1-kappa/(scFv-heavy-kappa)-h-CH2-CH3

  • 1/16

    Immobilized LAG-3 Protein, Human (HEK293, His, HY-P70722) can bind Bavunalimab. The EC50 for this effect is 62.34 ng/mL.

  • 1/16

    Immobilized CTLA-4 Protein, Human (HEK293, HY-P72959) can bind Bavunalimab. The EC50 for this effect is 8.452 ng/mL.

  • 1/16

    Flow Cytometry analysis of Raji cells labelling CTLA4 (red) with Bavunalimab (HY-P99354). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Bavunalimab Chemical Structure
    1/16
  • Bavunalimab
  • Immobilized LAG-3 Protein, Human (HEK293, His, HY-P70722) can bind Bavunalimab. The EC50 for this effect is 62.34 ng/mL.
  • Immobilized CTLA-4 Protein, Human (HEK293, HY-P72959) can bind Bavunalimab. The EC50 for this effect is 8.452 ng/mL.
  • Flow Cytometry analysis of Raji cells labelling CTLA4 (red) with Bavunalimab (HY-P99354). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • half-IGG1-kappa/(scFv-heavy-kappa)-h-CH2-CH3